Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tavocept in Advanced Primary Adenocarcinoma of the Lung
NCT00966914Phase 3Completed
- Sponsor
- BioNumerik Pharmaceuticals
- Start
- Apr 2010
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of dimesna in lung adenocarcinoma, sponsored by BioNumerik Pharmaceuticals. Started Apr 2010; status: completed.
02
Drugs
dimesna
03
Conditions
lung adenocarcinoma
Beyond the preview
Go deeper on NCT00966914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00966914.